| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/12/1994 | EP0577962A1 Nonionic radiographic contrast agents |
| 01/12/1994 | EP0577785A1 Fluorinated compounds as oxygen transport agents |
| 01/12/1994 | EP0577675A1 Contrast media |
| 01/12/1994 | EP0577659A1 Cross-linking agent. |
| 01/12/1994 | EP0423228B1 Immunoconjugates for cancer diagnosis and therapy |
| 01/11/1994 | US5278311 Nonionic radiographic contrast agents |
| 01/11/1994 | US5278042 Method for detecting inhibitors of tat protein |
| 01/11/1994 | US5277897 Coadministering to a cell |
| 01/11/1994 | US5277896 Clay enclosed transition and rare earth metal ions as contrast agents for the gastrointestinal tract |
| 01/11/1994 | US5277895 Nuclear magnetic resonance |
| 01/11/1994 | US5277893 Direct radiolabeling of substrates containing monosulfides or disulfide bonds with radionuclides |
| 01/11/1994 | US5277892 Administering a mixture of a lectin and a linked imaging ion |
| 01/06/1994 | WO1994000465A1 Novel sucrose ligands, methods for their preparation, platinum complexes derived therefrom, and methods for their usage |
| 01/06/1994 | CA2139414A1 Novel sucrose ligands, methods for their preparation, platinum complexes derived therefrom, and methods for their usage |
| 01/05/1994 | EP0577225A1 Diagnosis and treatment of inflammation |
| 01/05/1994 | EP0577215A1 Surface modified anticancer nanoparticles |
| 01/05/1994 | EP0576740A1 Process and device for the preparation of a contrast medium from a concentrate |
| 01/05/1994 | EP0576617A1 Composition and method containing optically pure (s) metoprolol. |
| 01/05/1994 | EP0576537A1 Debridement of bodily cavities using debridement fluids |
| 01/05/1994 | EP0576521A1 Improvements in or relating to contrast agents. |
| 01/05/1994 | EP0576519A1 Improvements in or relating to contrast agents |
| 01/05/1994 | EP0442962B1 Liposomal radiologic contrast agents |
| 01/04/1994 | US5276182 Process for preparing polyurea oligomers |
| 01/04/1994 | US5275801 13,17-propionic acid and propionic acid derivative substituted porphyrin complex compounds, process for their production and pharmaceutical agents containing them |
| 01/04/1994 | CA1325803C Useful compounds in particular for cancer radiotherapy and imagery and new steroid hormone receptors specific ligands |
| 12/29/1993 | EP0575360A1 Process of concentration and purification of organic compounds. |
| 12/29/1993 | EP0314690B1 Sigma brain receptor ligands and their use |
| 12/29/1993 | CN1079957A Compounds which can be used in congtrast products for radiography |
| 12/28/1993 | US5274082 Paramagnetic complexes of chelating compounds |
| 12/28/1993 | US5273743 Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent |
| 12/28/1993 | CA1325590C Concentrated stabilized microbubble-type ultrasonic imaging agent |
| 12/23/1993 | WO1993026019A1 Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications |
| 12/23/1993 | WO1993025895A1 Clay enclosed transition and rare earth metal ions as contrast agents for the gastrointestinal tract |
| 12/23/1993 | WO1993025243A2 Metal complexes formed with macrocyclic ligands for use in imaging techniques |
| 12/23/1993 | WO1993025242A1 Microparticles, method of producing them and their use for diagnostic purposes |
| 12/23/1993 | WO1993025241A1 Use of microcapsules as contrasting agents in colour doppler sonography |
| 12/23/1993 | DE4320307A1 New ferric 4-pyridon-3-olate complexes - useful as contrast agents for magnetic resonance imaging |
| 12/23/1993 | CA2138010A1 Microparticles, method of producing them and their use for diagnostic purposes |
| 12/23/1993 | CA2137145A1 Preparation of controlled size inorganic particles for use in separations, as magnetic molecular switches, and as inorganic liposomes for medical applications |
| 12/22/1993 | EP0524239B1 Insoluble salts of lanthanides for the visual display, using nuclear magnetic resonance, of the gastro-intestinal tract |
| 12/21/1993 | US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
| 12/21/1993 | US5271929 Nuclear magnetic resonance imaging agent comprising a di-aldehyde complex |
| 12/21/1993 | US5271928 Stable microbubbles suspensions injectable into living organisms |
| 12/21/1993 | US5271924 Low molecular weight polysaccharide complexes for nuclear magnetic resonance imaging |
| 12/21/1993 | US5271923 Solid radiographic contrast medium |
| 12/21/1993 | US5271401 Radiological imaging method |
| 12/16/1993 | DE4219724A1 Verwendung von Mikrokapseln als Kontrastmittel für die Farbdoppler-Sonographie Use of the microcapsules as a contrast agent for the color Doppler ultrasonography |
| 12/16/1993 | DE4219723A1 Mikropartikel, Verfahren zu deren Herstellung, sowie die Verwendung dieser in der Diagnostik Microparticles, methods for their preparation, as well as the use of these in diagnostics |
| 12/15/1993 | EP0573592A1 Gas and oxygen carrying lipid vesicles |
| 12/15/1993 | EP0573564A1 Nestin expression as an indicator of neuroepithelial tumors |
| 12/15/1993 | EP0562026A4 Balanced pressure solid fuel heating unit |
| 12/14/1993 | US5270320 Use of a 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the manufacture of a medicament for the treatment of cerebral and neuronal diseases |
| 12/14/1993 | US5270171 Cancer-associated SCM-recognition factor, preparation and method of use |
| 12/14/1993 | US5270030 Fibrin binding domain polypeptide and method of producing |
| 12/14/1993 | CA1325193C Class i mhc modulation of surface receptor activity |
| 12/09/1993 | WO1993024457A1 Azavesamicols |
| 12/09/1993 | WO1993024055A1 Method of quantitative determination of bone salt with ct equipment |
| 12/09/1993 | CA2134338A1 Azavesamicols |
| 12/08/1993 | EP0572553A1 Recombinant thrombin receptor and related pharmaceuticals |
| 12/08/1993 | EP0417129B1 Lung growth stimulatory and inhibitory factors for carcinoma tumor cells |
| 12/07/1993 | US5268371 Containing a radioactive metal |
| 12/07/1993 | US5268267 Using nucleic acid; hybridization |
| 12/07/1993 | US5268165 Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging |
| 12/07/1993 | US5268164 Intravascular administering a oligopeptide |
| 12/06/1993 | CA2095760A1 Nonionic radiographic contrast agents |
| 12/02/1993 | DE4217916A1 New heparin N-alkyl:amine and N-aralkyl:amine derivs. - useful as anticoagulants and intermediates for diagnostic tools |
| 12/01/1993 | EP0572287A2 Use of cyclic double-stranded oligonucleotides containing the binding site for a transcription factor for inhibiting gene expression |
| 12/01/1993 | EP0572049A2 Liposomes |
| 12/01/1993 | EP0571593A1 New non ionic iodized agents for x-ray contrasting, method for preparing them and galenical compositions containing them. |
| 12/01/1993 | EP0563179A4 Vascular catheter having low-profile distal end |
| 12/01/1993 | CN1078911A Preparing method for label of colonic transportation test |
| 11/30/1993 | US5266302 Calcein |
| 11/25/1993 | WO1993023743A1 Method of preparing a diagnostic agent for detecting inflammations |
| 11/25/1993 | WO1993023572A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 11/25/1993 | WO1993023365A1 Improved synthesis of ioversol |
| 11/25/1993 | WO1993023084A1 Drug screening and treatment for hiv thymocyte depletion |
| 11/25/1993 | WO1993023075A1 Treatment of vascular leakage syndrome and collagenase induced disease by administration of matrix metalloproteinase inhibitors |
| 11/25/1993 | CA2135882A1 Method of preparing a diagnostic agent for detecting inflammations |
| 11/25/1993 | CA2134653A1 Improved synthesis of ioversol |
| 11/25/1993 | CA2131700A1 Drug screening and treatment for hiv thymocyte depletion |
| 11/24/1993 | EP0570575A1 Bicycloazamacrocyclophosphonic acid, conjugates, contrast agents and preparation |
| 11/24/1993 | EP0233249B1 Non-ionic polyol contrast media from ionic contrast media |
| 11/24/1993 | CN1022839C Functionized polymine cheiants and rhodium complexes thereof and process for their preparation |
| 11/23/1993 | US5264610 Iodinated aromatic propanedioates |
| 11/23/1993 | US5264220 Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 11/23/1993 | US5264204 Nitroxide compounds |
| 11/23/1993 | US5263482 Thermographic imaging |
| 11/18/1993 | EP0570027A1 T cell receptor-specific for antigen polypeptides and related polynucleotides |
| 11/18/1993 | EP0569768A1 Means and method for the treatment of body fluids for the determination of neopterin |
| 11/18/1993 | EP0569583A1 Controlled use of polyether-substituted tumor agents in diagnosis and therapy |
| 11/18/1993 | EP0171407B1 Improvements relating to growth factors |
| 11/16/1993 | US5262176 Synthesis of polysaccharide covered superparamagnetic oxide colloids |
| 11/11/1993 | WO1993022670A1 Phosphorylated contrast agents for mri of the gi tract |
| 11/11/1993 | WO1993022662A1 Hydrophilic free radicals for magnetic resonance imaging |
| 11/11/1993 | WO1993022430A1 Development of a vector to target gene expression to the epidermis of transgenic animals |
| 11/11/1993 | WO1993022426A1 Live animal mutagenesis systems for testing mutagenic agents in vivo |
| 11/11/1993 | WO1993022275A1 Substituted 1,1,2-triphenylbutenes and their use in the treatment and diagnosis of cancer |
| 11/11/1993 | WO1993021961A1 Alkoxide-based layered mixed metal hydroxides as carriers for laser dyes |
| 11/11/1993 | WO1993021960A1 Nhr contrast agents |
| 11/11/1993 | WO1993021957A1 Complexing agents and targeting immunoreagents |